Commercial Metals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Commercial Metals Company (CMC) is expected to release Q3 earnings on Monday, with analysts anticipating EPS of $0.84, down from $1.02 year-over-year, and revenue of $2.04 billion, slightly below the previous year's $2.08 billion. Recent analyst actions show mixed sentiment, including an upgrade to Outperform from Wolfe Research, offset by price target reductions from UBS, Morgan Stanley, and Jefferies, indicating uncertainty despite generally positive ratings.

Analysis

Commercial Metals Company (CMC) is scheduled to release its third-quarter earnings on June 23, with market consensus anticipating a decline in financial performance. Analysts project quarterly earnings at $0.84 per share, a significant decrease from $1.02 per share reported in the same period last year, and forecast revenue at $2.04 billion, down from $2.08 billion year-over-year. This follows the company's second-quarter 2025 results, reported on March 20, where net sales fell 5.1% year-over-year to $1.754 billion, albeit broadly aligning with analyst expectations of $1.746 billion. Current analyst sentiment for CMC, which closed at $48.96 on Tuesday after a 1.1% gain, presents a mixed picture. While Wolfe Research upgraded the stock to Outperform from Peer Perform on May 27, 2025, other firms have expressed more caution: UBS maintained a Neutral rating but reduced its price target from $54 to $49 on March 24; Morgan Stanley kept an Equal-Weight rating while lowering its target from $56 to $53 on March 7; and Jefferies, despite a Buy rating, trimmed its price target from $65 to $62 on January 6. This pattern of price target reductions, even from analysts with positive or neutral stances, alongside a slightly negative ticker sentiment score of -0.2, suggests underlying concerns about the company's near-term outlook despite the recent upgrade.

Key Decisions for Investors

• Investors should closely monitor CMC's upcoming Q3 earnings release on June 23, particularly focusing on any deviation from the anticipated year-over-year declines in EPS and revenue, as well as management's forward guidance.
• Carefully weigh the recent upgrade from Wolfe Research against the multiple price target reductions from other analysts (UBS, Morgan Stanley, Jefferies) when assessing the stock's valuation and risk profile, especially in light of expected weaker financial results.
• Consider that the overall sentiment is mixed and slightly negative; thus, a cautious approach may be warranted, potentially involving a re-evaluation of position sizing or risk exposure ahead of the earnings announcement and subsequent market reaction.